The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Microbial Fermentation APIs Market Research Report 2024
Synopsis
Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. They are generally manufactured through a variety of processes that include chemical synthesis, fermentation processes, recombinant DNA, etc.
Microbial fermentation APIs are secondary metabolites produced by micro-organisms such as fungi and actinomycetes. The micro-organisms are capable of converting inexpensive carbon sources (starch, glucose, sucrose, etc.) and nitrogen sources (soybean flour, cotton-seed flour, peptone, etc.) into highly valuable API's or key intermediates (such as amino acids, vitamines, antibiotics) in liquid or solid media under certain growth conditions (nutrients, temperature, PH, oxygen supply).
Microorganisms that are typically used within the pharmaceutical industry include: prokaryotes such as Bacteria (e.g. Escherichia coli, Staphylococcus aureus) and Streptomycetes (e.g. Streptomyces spp, Actinomyces spp), eukaryotes such as Filamentous Fungi (e.g., Nigrospora spp, Aspergillus spp,) and Yeast (e.g. Saccharomyces cereviciae, Pichia pastoris).
The global Microbial Fermentation APIs market was valued at US$ 29370 million in 2023 and is anticipated to reach US$ 32410 million by 2030, witnessing a CAGR of 1.4% during the forecast period 2024-2030.
The major players in global Microbial Fermentation APIs market include Merck, Ajinomoto, HGPF, etc. China is the main market, and occupies about 50% of the global market. Antibiotics and Amino Acids are main types, with a share over 60%.
This report aims to provide a comprehensive presentation of the global market for Microbial Fermentation APIs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microbial Fermentation APIs.
Report Scope
The Microbial Fermentation APIs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Microbial Fermentation APIs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Microbial Fermentation APIs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Ajinomoto
HGPF
Huaxing
North China Pharmaceutical
Topfond
DSM
Tianyao
CSPC Pharma
Northeast Pharm
Lukang Pharmaceutical
Luwei Pharmaceutical
Jiangshan (DSM)
Segment by Type
Antibiotics
Amino Acids
Vitamin
Nucleotide
Organic Acid
Alcohol
Biological Products
Hormone
Segment by Application
Hospitals
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Microbial Fermentation APIs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Microbial Fermentation APIs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. They are generally manufactured through a variety of processes that include chemical synthesis, fermentation processes, recombinant DNA, etc.
Microbial fermentation APIs are secondary metabolites produced by micro-organisms such as fungi and actinomycetes. The micro-organisms are capable of converting inexpensive carbon sources (starch, glucose, sucrose, etc.) and nitrogen sources (soybean flour, cotton-seed flour, peptone, etc.) into highly valuable API's or key intermediates (such as amino acids, vitamines, antibiotics) in liquid or solid media under certain growth conditions (nutrients, temperature, PH, oxygen supply).
Microorganisms that are typically used within the pharmaceutical industry include: prokaryotes such as Bacteria (e.g. Escherichia coli, Staphylococcus aureus) and Streptomycetes (e.g. Streptomyces spp, Actinomyces spp), eukaryotes such as Filamentous Fungi (e.g., Nigrospora spp, Aspergillus spp,) and Yeast (e.g. Saccharomyces cereviciae, Pichia pastoris).
The global Microbial Fermentation APIs market was valued at US$ 29370 million in 2023 and is anticipated to reach US$ 32410 million by 2030, witnessing a CAGR of 1.4% during the forecast period 2024-2030.
The major players in global Microbial Fermentation APIs market include Merck, Ajinomoto, HGPF, etc. China is the main market, and occupies about 50% of the global market. Antibiotics and Amino Acids are main types, with a share over 60%.
This report aims to provide a comprehensive presentation of the global market for Microbial Fermentation APIs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microbial Fermentation APIs.
Report Scope
The Microbial Fermentation APIs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Microbial Fermentation APIs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Microbial Fermentation APIs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Ajinomoto
HGPF
Huaxing
North China Pharmaceutical
Topfond
DSM
Tianyao
CSPC Pharma
Northeast Pharm
Lukang Pharmaceutical
Luwei Pharmaceutical
Jiangshan (DSM)
Segment by Type
Antibiotics
Amino Acids
Vitamin
Nucleotide
Organic Acid
Alcohol
Biological Products
Hormone
Segment by Application
Hospitals
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Microbial Fermentation APIs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Microbial Fermentation APIs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Microbial Fermentation APIs Market Overview
1.1 Product Overview and Scope of Microbial Fermentation APIs
1.2 Microbial Fermentation APIs Segment by Type
1.2.1 Global Microbial Fermentation APIs Market Value Comparison by Type (2024-2030)
1.2.2 Antibiotics
1.2.3 Amino Acids
1.2.4 Vitamin
1.2.5 Nucleotide
1.2.6 Organic Acid
1.2.7 Alcohol
1.2.8 Biological Products
1.2.9 Hormone
1.3 Microbial Fermentation APIs Segment by Application
1.3.1 Global Microbial Fermentation APIs Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Research & Academic Laboratories
1.3.4 Pharmaceutical & Biotechnology Companies
1.4 Global Microbial Fermentation APIs Market Size Estimates and Forecasts
1.4.1 Global Microbial Fermentation APIs Revenue 2019-2030
1.4.2 Global Microbial Fermentation APIs Sales 2019-2030
1.4.3 Global Microbial Fermentation APIs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Microbial Fermentation APIs Market Competition by Manufacturers
2.1 Global Microbial Fermentation APIs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Microbial Fermentation APIs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Microbial Fermentation APIs Average Price by Manufacturers (2019-2024)
2.4 Global Microbial Fermentation APIs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Microbial Fermentation APIs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Microbial Fermentation APIs, Product Type & Application
2.7 Microbial Fermentation APIs Market Competitive Situation and Trends
2.7.1 Microbial Fermentation APIs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Microbial Fermentation APIs Players Market Share by Revenue
2.7.3 Global Microbial Fermentation APIs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Microbial Fermentation APIs Retrospective Market Scenario by Region
3.1 Global Microbial Fermentation APIs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Microbial Fermentation APIs Global Microbial Fermentation APIs Sales by Region: 2019-2030
3.2.1 Global Microbial Fermentation APIs Sales by Region: 2019-2024
3.2.2 Global Microbial Fermentation APIs Sales by Region: 2025-2030
3.3 Global Microbial Fermentation APIs Global Microbial Fermentation APIs Revenue by Region: 2019-2030
3.3.1 Global Microbial Fermentation APIs Revenue by Region: 2019-2024
3.3.2 Global Microbial Fermentation APIs Revenue by Region: 2025-2030
3.4 North America Microbial Fermentation APIs Market Facts & Figures by Country
3.4.1 North America Microbial Fermentation APIs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Microbial Fermentation APIs Sales by Country (2019-2030)
3.4.3 North America Microbial Fermentation APIs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Microbial Fermentation APIs Market Facts & Figures by Country
3.5.1 Europe Microbial Fermentation APIs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Microbial Fermentation APIs Sales by Country (2019-2030)
3.5.3 Europe Microbial Fermentation APIs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Microbial Fermentation APIs Market Facts & Figures by Country
3.6.1 Asia Pacific Microbial Fermentation APIs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Microbial Fermentation APIs Sales by Country (2019-2030)
3.6.3 Asia Pacific Microbial Fermentation APIs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Microbial Fermentation APIs Market Facts & Figures by Country
3.7.1 Latin America Microbial Fermentation APIs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Microbial Fermentation APIs Sales by Country (2019-2030)
3.7.3 Latin America Microbial Fermentation APIs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Microbial Fermentation APIs Market Facts & Figures by Country
3.8.1 Middle East and Africa Microbial Fermentation APIs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Microbial Fermentation APIs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Microbial Fermentation APIs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Microbial Fermentation APIs Sales by Type (2019-2030)
4.1.1 Global Microbial Fermentation APIs Sales by Type (2019-2024)
4.1.2 Global Microbial Fermentation APIs Sales by Type (2025-2030)
4.1.3 Global Microbial Fermentation APIs Sales Market Share by Type (2019-2030)
4.2 Global Microbial Fermentation APIs Revenue by Type (2019-2030)
4.2.1 Global Microbial Fermentation APIs Revenue by Type (2019-2024)
4.2.2 Global Microbial Fermentation APIs Revenue by Type (2025-2030)
4.2.3 Global Microbial Fermentation APIs Revenue Market Share by Type (2019-2030)
4.3 Global Microbial Fermentation APIs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Microbial Fermentation APIs Sales by Application (2019-2030)
5.1.1 Global Microbial Fermentation APIs Sales by Application (2019-2024)
5.1.2 Global Microbial Fermentation APIs Sales by Application (2025-2030)
5.1.3 Global Microbial Fermentation APIs Sales Market Share by Application (2019-2030)
5.2 Global Microbial Fermentation APIs Revenue by Application (2019-2030)
5.2.1 Global Microbial Fermentation APIs Revenue by Application (2019-2024)
5.2.2 Global Microbial Fermentation APIs Revenue by Application (2025-2030)
5.2.3 Global Microbial Fermentation APIs Revenue Market Share by Application (2019-2030)
5.3 Global Microbial Fermentation APIs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Microbial Fermentation APIs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Microbial Fermentation APIs Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Ajinomoto
6.2.1 Ajinomoto Corporation Information
6.2.2 Ajinomoto Description and Business Overview
6.2.3 Ajinomoto Microbial Fermentation APIs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Ajinomoto Microbial Fermentation APIs Product Portfolio
6.2.5 Ajinomoto Recent Developments/Updates
6.3 HGPF
6.3.1 HGPF Corporation Information
6.3.2 HGPF Description and Business Overview
6.3.3 HGPF Microbial Fermentation APIs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 HGPF Microbial Fermentation APIs Product Portfolio
6.3.5 HGPF Recent Developments/Updates
6.4 Huaxing
6.4.1 Huaxing Corporation Information
6.4.2 Huaxing Description and Business Overview
6.4.3 Huaxing Microbial Fermentation APIs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Huaxing Microbial Fermentation APIs Product Portfolio
6.4.5 Huaxing Recent Developments/Updates
6.5 North China Pharmaceutical
6.5.1 North China Pharmaceutical Corporation Information
6.5.2 North China Pharmaceutical Description and Business Overview
6.5.3 North China Pharmaceutical Microbial Fermentation APIs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 North China Pharmaceutical Microbial Fermentation APIs Product Portfolio
6.5.5 North China Pharmaceutical Recent Developments/Updates
6.6 Topfond
6.6.1 Topfond Corporation Information
6.6.2 Topfond Description and Business Overview
6.6.3 Topfond Microbial Fermentation APIs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Topfond Microbial Fermentation APIs Product Portfolio
6.6.5 Topfond Recent Developments/Updates
6.7 DSM
6.6.1 DSM Corporation Information
6.6.2 DSM Description and Business Overview
6.6.3 DSM Microbial Fermentation APIs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 DSM Microbial Fermentation APIs Product Portfolio
6.7.5 DSM Recent Developments/Updates
6.8 Tianyao
6.8.1 Tianyao Corporation Information
6.8.2 Tianyao Description and Business Overview
6.8.3 Tianyao Microbial Fermentation APIs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Tianyao Microbial Fermentation APIs Product Portfolio
6.8.5 Tianyao Recent Developments/Updates
6.9 CSPC Pharma
6.9.1 CSPC Pharma Corporation Information
6.9.2 CSPC Pharma Description and Business Overview
6.9.3 CSPC Pharma Microbial Fermentation APIs Sales, Revenue and Gross Margin (2019-2024)
6.9.4 CSPC Pharma Microbial Fermentation APIs Product Portfolio
6.9.5 CSPC Pharma Recent Developments/Updates
6.10 Northeast Pharm
6.10.1 Northeast Pharm Corporation Information
6.10.2 Northeast Pharm Description and Business Overview
6.10.3 Northeast Pharm Microbial Fermentation APIs Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Northeast Pharm Microbial Fermentation APIs Product Portfolio
6.10.5 Northeast Pharm Recent Developments/Updates
6.11 Lukang Pharmaceutical
6.11.1 Lukang Pharmaceutical Corporation Information
6.11.2 Lukang Pharmaceutical Microbial Fermentation APIs Description and Business Overview
6.11.3 Lukang Pharmaceutical Microbial Fermentation APIs Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Lukang Pharmaceutical Microbial Fermentation APIs Product Portfolio
6.11.5 Lukang Pharmaceutical Recent Developments/Updates
6.12 Luwei Pharmaceutical
6.12.1 Luwei Pharmaceutical Corporation Information
6.12.2 Luwei Pharmaceutical Microbial Fermentation APIs Description and Business Overview
6.12.3 Luwei Pharmaceutical Microbial Fermentation APIs Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Luwei Pharmaceutical Microbial Fermentation APIs Product Portfolio
6.12.5 Luwei Pharmaceutical Recent Developments/Updates
6.13 Jiangshan (DSM)
6.13.1 Jiangshan (DSM) Corporation Information
6.13.2 Jiangshan (DSM) Microbial Fermentation APIs Description and Business Overview
6.13.3 Jiangshan (DSM) Microbial Fermentation APIs Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Jiangshan (DSM) Microbial Fermentation APIs Product Portfolio
6.13.5 Jiangshan (DSM) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Microbial Fermentation APIs Industry Chain Analysis
7.2 Microbial Fermentation APIs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Microbial Fermentation APIs Production Mode & Process
7.4 Microbial Fermentation APIs Sales and Marketing
7.4.1 Microbial Fermentation APIs Sales Channels
7.4.2 Microbial Fermentation APIs Distributors
7.5 Microbial Fermentation APIs Customers
8 Microbial Fermentation APIs Market Dynamics
8.1 Microbial Fermentation APIs Industry Trends
8.2 Microbial Fermentation APIs Market Drivers
8.3 Microbial Fermentation APIs Market Challenges
8.4 Microbial Fermentation APIs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
